Innate lymphoid cells (ILCs) are a recently characterized family of immune cells that have critical roles in cytokine-mediated regulation of intestinal epithelial cell barrier integrity [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . Alterations in ILC responses are associated with multiple chronic human diseases, including inflammatory bowel disease, implicating a role for ILCs in disease pathogenesis 3, 8, [11] [12] [13] . Owing to an inability to target ILCs selectively, experimental studies assessing ILC function have predominantly used mice lacking adaptive immune cells [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . However, in lymphocyte-sufficient hosts ILCs are vastly outnumbered by CD4 1 T cells, which express similar profiles of effector cytokines. Therefore, the function of ILCs in the presence of adaptive immunity and their potential to influence adaptive immune cell responses remain unknown. To test this, we used genetic or antibody-mediated depletion strategies to target murine ILCs in the presence of an adaptive immune system. We show that loss of retinoic-acid-receptorrelated orphan receptor-ct-positive (RORct 1 ) ILCs was associated with dysregulated adaptive immune cell responses against commensal bacteria and low-grade systemic inflammation. Remarkably, ILCmediated regulation of adaptive immune cells occurred independently of interleukin (IL)-17A, IL-22 or IL-23. Genome-wide transcriptional profiling and functional analyses revealed that RORct 1 ILCs express major histocompatibility complex class II (MHCII) and can process and present antigen. However, rather than inducing T-cell proliferation, ILCs acted to limit commensal bacteria-specific CD4 1 T-cell responses. Consistent with this, selective deletion of MHCII in murine RORct 1 ILCs resulted in dysregulated commensal bacteria-dependent CD4 1 T-cell responses that promoted spontaneous intestinal inflammation. These data identify that ILCs maintain intestinal homeostasis through MHCIIdependent interactions with CD4 1 T cells that limit pathological adaptive immune cell responses to commensal bacteria.
ILCs are a heterogeneous population of innate immune cells that can be grouped based on their expression of, and developmental requirements for, specific transcription factors and cytokines 1, [8] [9] [10] . Group 1 ILCs depend on T-bet and express interferon (IFN)-c, whereas group 2 ILCs depend on ROR-a and GATA3 and express IL-5, IL-13 and amphiregulin 1, [8] [9] [10] . Group 3 ILCs critically depend on RORct for their development and in response to IL-23 stimulation produce the effector cytokines IL-17A and IL-22, which directly regulate innate immunity, inflammation and anatomical containment of pathogenic and commensal bacteria in the intestine 1, [8] [9] [10] 14 . However, the function of group 3 ILCs in the presence of adaptive immunity, and whether ILCs can influence adaptive immune cell responses, is unknown. To test this, adaptive immune cell responses were examined in mice lacking RORct (Rorc gfp/gfp ). In comparison to control mice, Rorc gfp/gfp mice exhibited significantly increased frequencies of peripheral proliferating Ki-67 1 CD4 1 T cells and effector/effector memory CD44 high CD62L low CD4 1 T cells ( Fig. 1a ) and developed splenomegaly ( Fig. 1b, c) , indicative of disrupted immune cell homeostasis. Rorc gfp/gfp mice also exhibited elevated levels of commensal bacteria-specific serum IgG ( Fig. 1d ), suggesting that commensal bacteria were promoting activation of adaptive immune cells in the absence of RORct. Consistent with this, oral administration of antibiotics to Rorc gfp/gfp mice was associated with significantly reduced peripheral Ki-67 1 CD4 1 T cells and CD44 high CD62L low CD4 1 T cells, spleen size and weight and commensal bacteria-specific serum IgG ( Fig. 1a-d ). As T cells also express RORct and RORct-deficient mice exhibit several developmental abnormalities 6, 15, 16 , we used CD90-disparate chimaeras to allow transient depletion of CD90.2 1 ILCs, but not CD90.1 1 T cells 3, 7 . Depletion of ILCs in CD90-chimaeric mice with an anti-CD90.2 monoclonal antibody resulted in significantly increased frequencies of dysregulated CD4 1 T cells, increased spleen weight and elevated commensal bacteriaspecific serum IgG responses ( Supplementary Fig. 1a-d ), suggesting a critical role for ILCs in the regulation of inflammatory adaptive immune cell responses to commensal bacteria. Unexpectedly, IL-22-, IL-17A-and IL-23-deficient mice did not exhibit altered CD4 1 T-cell responses, splenomegaly or elevated levels of commensal bacteriaspecific serum IgG ( Supplementary Fig. 2a -c). Furthermore, transient blockade of IL-22, IL-17A, IL-23 or IL-17RA in C57BL/6 mice also failed to exacerbate adaptive immune cell responses to commensal bacteria ( Supplementary Fig. 2d -i), indicating that ILCs regulate adaptive immune cell responses independently of effector cytokines.
To identify the mechanisms by which RORct 1 group 3 ILCs regulate commensal bacteria-responsive adaptive immune cells, genomewide transcriptional profiles of RORct 1 ILCs were compared to those of naive CD4 1 T cells ( Fig. 1e, f) . Analysis of the top differentially expressed transcripts in RORct 1 group 3 ILCs revealed a significant enrichment for genes involved in pathways of 'haematopoietic or lymphoid organ development' and 'immune response' (Fig. 1e ), consistent with previous analyses of RORct 1 ILCs 17, 18 . Notably, an additional pathway that was highly enriched in the transcriptional profile of group 3 ILCs was 'antigen processing and presentation of peptide antigen via MHCII' (Fig. 1e ). Indeed, relative to naive CD4 1 T cells ( Fig. 1f ) and previously published arrays of in-vitro-generated T-helper 17 cells 19 ( Supplementary Fig. 3 ), group 3 ILCs were highly enriched in transcripts involved in MHCII antigen processing and presentation pathways, such as Cd74, H2-DMb2, H2-DMa, H2-Ab1 and H2-Aa. Consistent with these transcriptional analyses, MHCII protein was detected on gated lineage 2 CD45 1 RORct 1 ILCs from the mesenteric lymph node of naive RORct-eGFP reporter mice ( Fig. 1g ). Critically, MHCII protein was also identified on gated lineage 2 CD127 1 RORct 1 ILCs from the small intestine of healthy humans ( Fig. 1h ). Collectively, these results indicate that group 3 RORct 1 ILCs in the intestinal and lymphoid tissues of healthy mice and humans express MHCII.
To interrogate whether MHCII expression was restricted to group 3 ILCs, total lineage 2 CD45 1 CD90.2 1 ILCs in the murine small intestine were subdivided into group 1, 2 and 3 ILCs by expression of their defining transcription factors ( Fig. 2a, b and Supplementary Fig. 4a-e ). Group 1 ILCs (RORct 2 T-bet 1 NKp46 1/2 ) were found to lack MHCII expression ( Supplementary Fig. 4d -f), whereas group 2 ILCs (GATA-3 1 ) expressed intermediate levels of MHCII ( Supplementary Fig. 4c ). Microarray analyses confirmed the enrichment of MHCII-associated genes in group 3 ILCs versus previously published arrays of group 1 ILCs, such as natural killer (NK) cells 20 ( Supplementary Fig. 5a ) and group 2 ILCs 17 ( Supplementary Fig. 5b ). Significant heterogeneity exists within RORct 1 group 3 ILCs and three subgroups can be identified on the basis of expression of NKp46 and T-bet ( Fig. 2a) 9, 10, 21 . MHCII was found to be highly expressed on RORct 1 ILCs that lacked expression of both T-bet and NKp46, whereas minimal expression of MHCII was observed on RORct 1 T-bet 1 NKp46 2 and RORct 1 Tbet 1 NKp46 1 ILC subsets ( Fig. 2b ) isolated from the small intestine of naive mice. Consistent with this, previously published microarray data profiling ILCs based on NKp46 and RORct expression 18 also revealed an enrichment of MHCII-associated genes in RORct 1 ILCs that lacked NKp46 and T-bet expression ( Supplementary Fig. 5c ).
Furthermore, MHCII 1 RORct 1 ILCs were found in lymphoid tissues at steady state ( Supplementary Fig. 6 ), exhibited homogeneous expression of CD127, CD90.2, CD25, CCR6, c-kit and CD44, and heterogeneous expression of Sca-1 and CD4 ( Supplementary Fig. 7a ) and produced IL-22, but not IL-17A or IFN-c, in response to IL-23 stimulation ( Supplementary Fig. 7b ).
To interrogate the functional capacity of MHCII 1 ILCs, cells were sort-purified and cultured with DQ-ovalbumin (DQ-OVA), a selfquenching conjugate of ovalbumin that fluoresces upon proteolytic degradation. MHCII 1 ILCs exhibited an increase in fluorescence intensity comparable to CD11c 1 MHCII 1 dendritic cells after incubation with DQ-OVA ( Fig. 2c ), indicative of an ability to acquire and degrade antigens. Sort-purified ILCs were also cultured with green fluorescent protein (GFP)-labelled E-alpha (Ea) protein and stained with an antibody specific for Ea-derived Ea 52-68 peptide bound to I-A b molecules (Y-Ae). MHCII 1 ILCs incubated with GFP-Ea exhibited positive GFP fluorescence and staining for Y-Ae at levels comparable to those of CD11c 1 MHCII 1 dendritic cells ( Fig. 2d ), demonstrating that ILCs can process exogenous protein and present peptide antigen in the context of MHCII. However, in contrast to OVA-pulsed dendritic cells that induced multiple rounds of ovalbumin-specific CD4 1 T-cell proliferation, OVA-pulsed ILCs failed to induce ovalbumin-specific CD4 1 T-cell proliferation ( Fig. 2e ). Consistent with this, MHCII 1 RORct 1 ILCs lacked expression of the classical co-stimulatory molecules CD40, CD80 and CD86, relative to dendritic cells ( Fig. 2f ). Antigen presentation in the absence of costimulatory molecules has been proposed to limit T-cell responses 22 
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T-cell responses in vivo. To test this, ILCs were pulsed with the commensal bacteria-derived antigen CBir1 (ref. 23 ) and co-transferred with CBir1-specific transgenic T cells into naive congenic mice, before systemic challenge with peptide ( Supplementary Fig. 8a ). Mice that received a co-transfer of CBir1-specific T cells with peptide-pulsed ILCs exhibited a reduced population expansion of transferred T cells and decreased antigen-specific IFN-c production relative to transfer of T cells alone ( Supplementary Fig. 8b-d ), suggesting that antigen presentation by ILCs limits CD4 1 T-cell responses in vivo.
To investigate further the ability of MHCII 
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mice with a floxed H2-Ab1 gene (H2-Ab1 fl ) with mice expressing Cre recombinase under the control of the Rorc promoter (Rorc cre ) ( Supplementary Fig. 9a ). Given that Rorc is expressed only by T cells and ILCs 15, 16 and that murine T cells do not express MHCII 24 , this permitted selective genetic deletion of MHCII in RORct 1 ILCs in the presence of an intact adaptive immune system. Consistent with this, MHCII DILC mice exhibited a selective loss of MHCII expression on RORct 1 ILCs, whereas B cells, dendritic cells and macrophages retained comparable expression levels of MHCII relative to control H2-Ab1 fl mice ( Supplementary Fig. 9b ). MHCII DILC mice also had comparable peripheral numbers of lymph nodes and Peyer's patches, frequencies of ILCs and production of ILC-derived IL-22 (Supplementary Fig. 9c, d ) as compared to control mice. However, MHCII DILC mice did exhibit significantly increased frequencies of peripheral Ki-67 1 CD4 1 T cells and CD44 high CD62L low CD4 1 T cells, increased spleen size and weight and a significant increase in commensal bacteria-specific serum IgG, which were abrogated upon oral administration of antibiotics ( Fig. 3a-d) . Thus, loss of ILC-intrinsic MHCII expression recapitulated the phenotype observed after genetic or antibody-mediated depletion of ILCs (Fig. 1a-d and Supplementary  Fig. 1a-d) identifying a critical role for MHCII 1 ILCs in regulating T-cell responses to commensal bacteria. Inappropriate host inflammatory responses to commensal bacteria are associated with the pathogenesis and progression of numerous chronic human diseases 3, [11] [12] [13] , therefore MHCII DILC mice were examined at various ages for signs of inflammation. MHCII DILC mice were observed to develop rectal prolapse, beginning at approximately 8 weeks of age and reaching a 100% incidence by 18 weeks of age (Fig. 3e ). Further examination revealed that MHCII DILC mice exhibited intestinal inflammation characterized by crypt elongation, loss of normal architecture and significantly decreased colon length (Fig. 3f, g) . Intestinal inflammation in MHCII DILC mice could be prevented by continuous administration of antibiotics ( Fig. 3e-g) , demonstrating a critical role for commensal bacteria in the development of disease. Moreover, MHCII DILC mice exhibited significantly elevated frequencies of IFN-c 1 , IL-17A 1 and TNF-a 1 CD4 1 T cells in the colon (Fig. 3h ), including CD4 1 T cells that co-produced IFN-c and IL-17A (Fig. 3i) , which was associated with significant recruitment of neutrophils into the colonic lamina propria (Fig. 3j ). Further phenotypic and functional analyses suggested that the increased pro-inflammatory CD4 1 T-cell responses and intestinal inflammation that developed in the absence of ILC-intrinsic MHCII were not the result of impaired regulatory T-cell function or regulatory cytokine production (Supplementary Fig. 10 ), altered thymic selection ( Supplementary Fig. 11 ) or commensal microflora dysbiosis ( Supplementary Fig. 12 ). Collectively, these data suggest that ILCs directly limit commensal bacteriaresponsive CD4 1 T cells through MHCII-dependent interactions.
To determine whether dysregulated CD4 1 T-cell responses to commensal bacteria directly promoted intestinal inflammation observed in MHCII DILC mice, sort-purified CD4 1 T cells from control H2-Ab1 fl mice or MHCII DILC mice were transferred into Rag1 2/2 mice. In comparison to Rag1 2/2 recipients receiving CD4 1 T cells from control mice, Rag1 2/2 recipients receiving CD4 1 T cells from MHCII DILC mice exhibited rapid and substantial weight loss (Fig. 4a ), colonic shortening, macroscopic intestinal thickening and severe intestinal inflammation characterized by crypt elongation, loss of normal architecture and inflammatory cell infiltrates ( Fig. 4b-d ). Critically, oral administration of antibiotics to MHCII DILC donor mice before CD4 1 T-cell isolation abrogated the ability of CD4 1 T cells to elicit wasting disease and intestinal inflammation in naive Rag1 2/2 recipients ( Fig. 4a-d) . Similarly, germ-free Rag1 2/2 recipients of CD4 1 T cells from MHCII DILC mice did not develop wasting disease or intestinal inflammation in comparison to conventional Rag1 2/2 recipients ( Fig. 4e-g) . Therefore, in the absence of RORct 1 ILC-intrinsic MHCII, commensal bacteria are required for both the development of pathological CD4 1 T-cell responses and for the onset of wasting disease and intestinal inflammation.
Collectively, these data identify a previously unrecognized role for RORct 1 ILCs in maintaining intestinal homeostasis by limiting pathological CD4 1 T-cell responses to commensal bacteria through MHCIIdependent interactions ( Supplementary Fig. 13 ). MHCII expression was found to be restricted to a subset of CCR6 1 RORct 1 ILCs that lack T-bet and IFN-c expression and thus, are phenotypically and functionally distinct from RORct 1 ILC populations that have been associated with promoting intestinal inflammation in murine models and inflammatory bowel disease patients 2,11 . Rather, MHCII 
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ILCs are more similar to IL-22-producing ILC populations previously shown to promote tissue protection 3, 5, 8, [12] [13] [14] . In a developmental context, it is remarkable that RORct 1 ILCs are the first cells of the immune system to colonize the neonatal intestine and gut-associated lymphoid tissues 15, 25, 26 . Therefore, ILCs may have a critical role not only in promoting lymphoid organogenesis and cytokine-mediated epithelial cell barrier integrity but also in regulating adaptive immune cell responses to newly colonizing commensal bacteria. It may also be advantageous for ILCs to modulate commensal bacteria-specific T cells as, in contrast to professional antigen presenting cells, murine ILCs lack expression of TLRs, conventional co-stimulatory molecules and do not produce cytokines that regulate T-cell differentiation 1, 8, 10, 25 .
The demonstration that ILCs regulate adaptive immune cell responses to commensal bacteria through a MHCII-dependent mechanism may be of importance in understanding the pathogenesis of numerous chronic human diseases associated with inflammatory host immune responses to commensal bacteria.
METHODS SUMMARY
MHCII DILC mice were generated by crossing H2-Ab1 fl mice with Rorc cre mice. H2-Ab1 fl littermates were used as controls for all experiments. Intestinal lamina propria and lymphoid tissue cell suspensions were isolated as previously described 3, 7 .
In some experiments mice were treated with antibiotics as previously described 3 .
Commensal bacteria-derived antigen-specific enzyme-linked immunosorbent assays (ELISAs) were performed by coating 96-well plates with 5 mg ml 21 crude commensal bacteria antigen, prepared by isolation of faecal contents and sequential homogenization and sonication. ILCs were identified by exclusion of lineagepositive cells by staining with fluorochrome-conjugated antibodies against CD3, CD5, CD8a, CD11c, NK1.1 and B220 and by positive expression of CD45 and CD90.2 or by expression of GFP in RORct-eGFP mice. Sort-purified ILCs and dendritic cells were assessed for antigen processing and presentation capacity by culturing cells with 10 mg ml 21 DQ-OVA for 3 h or by culturing for 3 h with 50 mg ml 21 GFP-labelled E-alpha protein, followed by subsequent staining with an antibody recognizing Ea 52-68 peptide bound to I-A b . Lymphocyte populations ($95%) were sort-purified using a BD FACS Aria II. CD4 1 T cells were adoptively transferred to conventional or germ-free Rag1 2/2 recipients via intravenous injection. Data are represented as the mean 6 s.e.m. and statistical significance was determined by the Student's t-test.
METHODS
Mice, antibiotics and use of monoclonal antibodies in vivo. C57BL/6 mice, C57BL/6 Rag1 2/2 , C57BL/6 CD90.1 and C57BL/6 Rorc gfp/gfp mice were purchased from the Jackson Laboratory, bred and maintained at the University of Pennsylvania. C57BL/6 Il17a 2/2 mice were provided by Y. Iwakura (University of Tokyo), C57BL/6 Il22 2/2 mice were provided by Pfizer, Il23a 2/2 mice were provided by Janssen Research & Development LLC, H2-Ab1 fl mice were provided by P. A. Koni, tissues from CBir1 TCR transgenic mice were provided by C. O. Elson, and Rorc cre mice and Rorc(ct)-Gfp TG were provided by G. Eberl. All mice were maintained in specific pathogen-free facilities at the University of Pennsylvania. Germ-free C57BL/6 and C57BL/6 Rag1 2/2 mice were provided by the University of Pennsylvania Gnotobiotic Mouse Facility. CD90-disparate Rag1 2/2 chimaeras were constructed as previously described 3, 7 . All protocols were approved by the University of Pennsylvania Institutional Animal Care and Use Committee (IACUC), and all experiments were performed according to the guidelines of the University of Pennsylvania IACUC. A previously described cocktail of antibiotics was continuously administered via drinking water for defined periods of time 3, 27 . Anti-CD90.2 monoclonal antibody (30H12) was purchased from BioXCell. Anti-IL-22 monoclonal antibodies, IL22-01 (neutralizing) and IL22-02 (mouse cytokine detection) were developed by Pfizer. Anti-IL-17A monoclonal antibody (CNTO 8096) and anti-IL-23p19 monoclonal antibody (CNTO 6163) were developed by Janssen Research & Development, LLC. Anti-IL-17RA monoclonal antibody was developed by Amgen Inc. Neutralizing or depleting monoclonal antibodies were administered intraperitoneally every 3 days at a dose of 250 mg per mouse starting on day 0 and ending on day 14.
Murine tissue isolation and flow cytometry. Spleens, lymph nodes and Peyer's patches were harvested, and single-cell suspensions were prepared at necropsy as previously described 3, 7 . For intestinal lamina propria lymphocyte preparations, intestines were isolated, attached fat removed and tissues cut open longitudinally. Luminal contents were removed by shaking in cold PBS. Epithelial cells and intraepithelial lymphocytes were removed by shaking tissue in stripping buffer (1 mM EDTA, 1 mM DTT and 5% FCS) for 30 min at 37 uC. The lamina propria layer was isolated by digesting the remaining tissue in 0.5 mg ml 21 collagenase D (Roche) and 20 mg ml 21 DNase I (Sigma-Aldrich) for 30 min at 37 uC. For flow cytometric analyses, cells were stained with antibodies to the following markers: anti-NK1.1 (clone PK136, eBioscience), anti-CD3 (clone 145-2C11, eBioscience), anti-CD5 (clone 53-7.3, eBioscience), anti-CD90.2 (clone 30-H12, BioLegend), anti-CD127 (clone A7R34, eBioscience), anti-CD11c (clone N418, eBioscience), anti-F4/80 (clone BM8, eBioscience), anti-CD4 (clone GK1.5, Abcam), anti-CD8 (clone 53-6.7, eBioscience), anti-B220 (clone RA3-6B2, eBioscience), anti-CD25 (clone eBio3C7, eBioscience), anti-MHCII (clone M5/114.15.2, eBioscience), anti-CD44 (clone IM7, eBioscience), anti-CD62L (clone MEL-14, eBioscience), anti-CD45 (clone 30-F11, eBioscience), anti-NKp46 (clone 29A1.4, eBioscience), anti-CD11b (clone M1/70, eBioscience), anti-CD117 (c-kit) (clone 2B8, eBioscience), anti-Sca-1 (clone D7, eBioscience), anti-CD40 (clone 1C10, eBioscience), anti-CD80 (clone 16-10A1, eBioscience), anti-CD86 (clone GL1, BD Biosciences), anti-Ly6G (clone 1A8, BioLegend) and anti-CCR6 (clone 29-2L17, BioLegend). For intracellular staining, cells were fixed and permeabilized using a commercially available kit (eBioscience) and stained with anti-RORct (clone B2D, eBioscience), anti-FoxP3 (clone FJK016s, eBioscience), anti-T-bet (clone eBio-4B10, eBioscience), anti-GATA-3 (clone TWAJ, eBioscience) or anti-Ki-67 (clone B56, BD Biosciences). For cytokine production, cells were stimulated ex vivo by incubation for 4 h with 50 ng ml 21 PMA, 750 ng ml 21 ionomycin, 10 mg ml 21 brefeldin A (all obtained from Sigma-Aldrich) or 50 ng ml 21 rIL-23 (eBioscience) and 10 mg ml 21 brefeldin A. Cells were fixed and permeabilized as indicated above and stained with IL22-02 (Pfizer) conjugated to Alexa Fluor 647 or Alexa Fluor 488 according to the manufacturer's instructions (Molecular Probes), anti-IL-17A (clone eBioTC11-18H10.1, eBioscience), anti-IFN-c (clone XMG1.2, eBioscience) and anti-TNF-a (clone MP6-XT22, eBioscience). Dead cells were excluded from analysis using a violet viability stain (Invitrogen). T-cell Vb chain usage was assessed using a commercial mouse Vb TCR screening panel (BD Biosciences). Flow cytometry data collection was performed on a LSR II (BD Biosciences) and cell sorting performed on an Aria II (BD Biosciences). Data were analysed using FlowJo software (Tree Star Inc.). Human intestinal samples and flow cytometry. Human intestinal tissues from the ileum were obtained from the Cooperative Human Tissue Network. Single cell suspensions from intestinal tissues were obtained by cutting tissues into small pieces and incubating for 1-2 h at 37 uC with shaking in stripping buffer (1 mM EDTA, 1 mM DTT and 5% FCS) to remove the epithelial layer. Supernatants were then discarded, and the lamina propria fraction was obtained by incubating the remaining tissue for 1-2 h at 37 uC with shaking in collagenase solution. Remaining tissues were then mechanically dissociated, filtered through a wire mesh tissue sieve, and lymphocytes were subsequently separated by Ficoll gradient.
For flow cytometry, cells were stained with antibodies to the following markers: anti-CD3 (clone UCHT1, eBioscience), anti-CD56 (clone CMSSB, eBioscience), anti-CD19 (clone 2H7, eBioscience), anti-HLA-DR (clone LN3, eBioscience), anti-CD127 (clone A019D5, Biolegend). For intracellular staining, cells were fixed and permeabilized using a commercially available kit (eBioscience) and stained with anti-RORct (clone AFKJS-9, eBioscience) and anti-IL-22 (clone 22URTI, eBioscience). Dead cells were excluded from analysis using a viability stain (Invitrogen). Flow cytometry data was collected using a LSR II (BD Biosciences). Data were analysed using FlowJo software (Tree Star Inc.). Histological sections. Tissue samples from the intestines of mice were fixed with 4% paraformaldehyde, embedded in paraffin, and 5 mm sections were stained with haematoxylin and eosin. Microarray and DAVID pathway analysis. Microarray gene expression profiling and data normalization for group 2 ILCs (sorted Lineage -, CD90.2 1 , CD25 1 ILCs from the lungs of naive C57BL/6 mice), group 3 ILCs (Lineage -, CD90.2 1 , CD4 1 ILCs from the spleens of naive C57BL/6 mice) and naive splenic CD4 1 T cells were performed as previously described (GEO accession numbers; GSE46468 and GSE30437), data were RMA-normalized and SAM analysis was performed 17 . Additional microarray gene expression profiling were obtained from GEO for previously published studies of in vitro polarized T H 17 cells (GSM1074979, GSM1075001 and GSM1075002) 19 , splenic NK cells (GSM538315, GSM538316 and GSM538317) 20 and subsets of RORc 1 ILCs isolated from naive murine small intestine (GSM739586, GSM739591, GSM739588, GSM739593, GSM739589 and GSM739594) 18 . GEO data sets were batch-corrected to existing microarray gene expression profiles using ComBat 28 . Differentially expressed genes in the transcriptional profiles of specified groups were uploaded to the Database for Annotation, Visualization and Integrated Discovery (DAVID, http://david.abcc.ncifcrf.gov/) 29 and analysed as previously described 17 using the Fisher's exact test to identify significantly enriched Gene Ontology (GO, http://www.geneontology.org) terms 29 . Heat maps displaying key genes were generated using Mayday software 30 . Antigen processing and presentation analyses. 2 3 10 3 sort-purified CD11c 1 MHCII 1 dendritic cells and lineage 2 CD127 1 c-kit 1 MHCII 1 ILCs were cultured with 10 mg ml 21 DQ-OVA (Molecular Probes) at 4 uC or 37 uC for 3 h, extensively washed and fluorescence assessed via flow cytometry. Alternatively, antigen processing and presentation were assessed using a previously defined selfantigen E-alpha 31 . Briefly, 2 3 10 3 sort-purified dendritic cells and ILCs were pulsed for 3 h in complete media with 50 mg ml 21 GFP-labelled E-alpha protein, extensively washed and stained with a biotin-conjugated antibody recognizing Ea 52-68 peptide bound to I-A b (clone Yae, eBioscience) followed by a streptavidin APC (eBioscience) and uptake of antigen and peptide-MHCII complex presentation assessed via flow cytometry. In some assays 2 3 10 3 sort-purified dendritic cells or ILCs were pulsed with 50 mg ovalbumin for 2 h before incubation with 2 3 10 4 sort-purified CFSE-labelled OT-II T cells. Cell co-cultures were incubated for 72 h before analysis via flow cytometry. T-cell adoptive transfer. 2 3 10 6 CD4 1 CD3 1 T cells were sorted from the spleen and mesenteric lymph node of control or experimental mice to a purity .97% and transferred intravenously to naive C57BL/6 Rag1 2/2 recipient mice (GF or CNV). Weights of recipient mice were monitored through the progression of the experiment. CBir1-specific T-cell transfers. 1 3 10 6 CBir1 TCR transgenic T cells were transferred into congenically marked hosts with or without co-transfer of 8 3 10 3 sortpurified ILCs (lineage 2 CD127 1 c-kit 1 ) pulsed with 1 mg ml 21 CBir1 456-475 peptide. Twenty-four hours later mice were administered 50 mg CBir1 456-475 peptide intraperitoneally and 72 h later mice were euthanized and the presence of CBir1 TCR transgenic T cells was quantified in the spleen. IFN-c production was quantified by culturing 1 3 10 6 splenocytes in the presence of 1 mg ml 21 CBir1 456-475 peptide for 48 h.
Regulatory T-cell suppression assay. CD11c 1 dendritic cells, naive CD4 1 CD25 2 CD45RB hi T effector (T eff ) cells and CD4 1 CD25 1 CD45RB 2 regulatory T cells (T reg ) cells were sort-purified from the spleen and mesenteric lymph node of MHCII DILC mice and littermate controls. Sort-purified T reg cells were found to be at least 98% FoxP3 1 . Dendritic cells were plated at 5 3 10 3 per well in the presence or absence of 1 mg ml 21 soluble purified anti-CD3 (clone 145-2C11, BD Biosciences). T eff cells were CFSE labelled and added to wells containing dendritic cells at 2.5 3 10 4 alone, or with T reg at a ratio of 1:0, 1:2, 1:4, 1:8 and 1:16. After 3 days culture at 37 uC/5% CO 2 , cell-culture supernatants were harvested and T eff proliferation was measured by CFSE dilution via flow cytometry. T reg suppression was calculated by gating on T effector cells and quantifying the percentage of CFSE-dim in comparison to cells cultured in the absence of T reg cells. Quantitative real-time PCR. RNA was isolated from whole colon tissue that was homogenized and snap frozen in Trizol reagent (Invitrogen). RNA was isolated as per the manufacturer's instructions and cDNA generated using Superscript reverse transcription (Invitrogen). Real-time PCR was performed on cDNA using RESEARCH LETTER
